354 related articles for article (PubMed ID: 36183999)
21. Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway.
Polimeni M; Gulino GR; Gazzano E; Kopecka J; Marucco A; Fenoglio I; Cesano F; Campagnolo L; Magrini A; Pietroiusti A; Ghigo D; Aldieri E
Part Fibre Toxicol; 2016 Jun; 13(1):27. PubMed ID: 27251132
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
23. aV integrins and TGF-β-induced EMT: a circle of regulation.
Mamuya FA; Duncan MK
J Cell Mol Med; 2012 Mar; 16(3):445-55. PubMed ID: 21883891
[TBL] [Abstract][Full Text] [Related]
24. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
25. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
[TBL] [Abstract][Full Text] [Related]
26. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R
PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585
[TBL] [Abstract][Full Text] [Related]
27. Total flavone of
Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ
World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880
[TBL] [Abstract][Full Text] [Related]
28. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
Ihara H; Mitsuishi Y; Kato M; Takahashi F; Tajima K; Hayashi T; Hidayat M; Winardi W; Wirawan A; Hayakawa D; Kanamori K; Matsumoto N; Yae T; Sato T; Sasaki S; Takamochi K; Suehara Y; Ogura D; Niwa SI; Suzuki K; Takahashi K
Respir Investig; 2020 Jul; 58(4):275-284. PubMed ID: 32359980
[TBL] [Abstract][Full Text] [Related]
29. JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-β.
Gervasi M; Bianchi-Smiraglia A; Cummings M; Zheng Q; Wang D; Liu S; Bakin AV
J Cell Biol; 2012 Mar; 196(5):589-603. PubMed ID: 22391036
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-Mesenchymal Transition by Synergy between Transforming Growth Factor-β and Growth Factors in Cancer Progression.
Saitoh M
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140527
[TBL] [Abstract][Full Text] [Related]
31. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.
Tsubakihara Y; Moustakas A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463358
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
34. Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway.
Choi D; Kim CL; Kim JE; Mo JS; Jeong HS
Biochem Biophys Res Commun; 2020 Jul; 528(1):154-159. PubMed ID: 32451085
[TBL] [Abstract][Full Text] [Related]
35. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
36. Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smad- and epithelial-mesenchymal transition signaling pathways.
Liu SF; Chang SY; Lee TC; Chuang LY; Guh JY; Hung CY; Hung TJ; Hung YJ; Chen PY; Hsieh PF; Yang YL
PLoS One; 2012; 7(11):e47482. PubMed ID: 23144821
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing in EMT and TGF-β signaling during cancer progression.
Zhang YE; Stuelten CH
Semin Cancer Biol; 2024 Jun; 101():1-11. PubMed ID: 38614376
[TBL] [Abstract][Full Text] [Related]
38. Lefty-1 inhibits renal epithelial-mesenchymal transition by antagonizing the TGF-β/Smad signaling pathway.
Zhang L; Liu X; Liang J; Wu J; Tan D; Hu W
J Mol Histol; 2020 Feb; 51(1):77-87. PubMed ID: 32065356
[TBL] [Abstract][Full Text] [Related]
39. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
[TBL] [Abstract][Full Text] [Related]
40. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.
Rajasekaran SA; Huynh TP; Wolle DG; Espineda CE; Inge LJ; Skay A; Lassman C; Nicholas SB; Harper JF; Reeves AE; Ahmed MM; Leatherman JM; Mullin JM; Rajasekaran AK
Mol Cancer Ther; 2010 Jun; 9(6):1515-24. PubMed ID: 20501797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
